Single-protein analysis to unlock the power of proteomics.

Personalized medicine by single-protein analysis.

Unomr is a deep-tech startup from ETH that is developing a patented analytical instrument to revolutionize medical research. By measuring individual biomolecules with unattainable accuracy and sensitivity, we give academic research as well as biotech and pharmaceutical companies new tools to study the effects of pharmaceutical products. With our serial nanopore technology, our customers can develop treatments for diseases that are currently incurable more quickly and efficiently. Our vision is to enable the analysis of rare proteins such as cancer biomarkers and protein sequencing with our team of experts who have years of experience in the development of biosensors.